Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian
Tell us : are you a UK centenarian or do you know one ?
4/11/2025
Houseplant hacks : can a plastic bag revive a wilting fern ?
4/11/2025
‘I want to ride out on a unicorn every night’ : swords’n’sorcery heavy metal band Castle Rat
4/11/2025
Tom’s Crossing by Mark Z Danielewski – House of Leaves author returns with a 1200-page western
4/11/2025
Apple Watch SE 3 review : the bargain smartwatch for iPhone
4/11/2025
London Ulez auto pay blunders have triggered £11,445 in fines
4/11/2025